Applied Clinical Trials Magazine

🚨Our June issue is LIVE🚨 How much does a day of delay in a clinical trial really cost?🔺Aligning patient burden with planetary burden🔺Guiding principles for trial participant communication🔺and so much more right here ➡️ https://lnkd.in/ej4vGbZv

Live Next Week: A Patient-First Approach to Clinical Research: A Conversation With Industry Leaders Tune in to our live webinar with YPrime as Julie McKenzie uncover insights on designing clinical trials that meet regulatory and scientific standards. Learn how to prioritize patient needs and experiences, ensuring they are at the heart of every decision. Register now: https://lnkd.in/gfCq5vDg

📹 In part 2 of this video interview, Kristy Birchard, product owner, patient engagement, YPrime discusses the work she is currently doing within #patientcentricity and how to effectively reach patient communities

Patients administered donidalorsen experienced a lower hereditary angioedema (HAE) attack rate, which indicates the potential for prophylactic use in treating HAE

Clinical trials can offer patients who have run out of options with another chance at treatment. Unfortunately, actually getting enrolled in #clinicaltrials is a much more complicated process than many people realize. Nick Slack, MBE, chairman and CEO of The START Center for Cancer Research, spoke with Applied Clinical Trials Magazine's sister brand, Pharmaceutical Executive about how his company works to make this easier on patients💬🗨️

What does #diversity in #clinicaltrials really mean? The FDA's new Diversity Action Plan Guidance emphasizes what we've paid a lot more attention to in recent years, such as race, ethnicity, age of participants, and sex of participants, but also pays close attention to geographical location, socioeconomic status, disabilities, and more. In this Applied Clinical Trials Magazine video interview, Curavit's CMO and Co-Founder, Pam D., says she hopes "that these guidelines will lead to greater trust across the industry, whether it's increased trust between sponsors and regulatory organizations, but more importantly, in [her] mind, hoping it will increase trust between sponsors, CROs, and potential trial participants." #DTx #DCTs #digitalhealth #pharma #biotech #clinicalresearch Hear more from Pam and other industry experts on the new plan guidance here: https://lnkd.in/g6WXYdpj

"Thank you!" to my colleague and co-founder Pam D., CMO of Curavit for participating in this important discussion with her colleagues from Advarra and Medable, Inc at Applied Clinical Trials Magazine on the FDA's evolving support for #diversity in #clinicaltrials.

Communication is key to recruiting and engaging patients throughout your clinical trial. In an Applied Clinical Trials Magazine article, Rebecca Starkie shares insights from surveying patients about their clinical trial participation. Read the article: https://hubs.la/Q02F7cXC0 #PatientEngagement #ClinicalTrials #ClinicalResearch #PatientExperience

📹 Pamela Tenaerts, MD, MBA, chief scientific officer, Medable, Inc; Luke Gelinas, PhD, senior chair director, Advarra; and Pam D. medical officer & co-founder, Curavit highlight the potential impact FDA's Diversity Action Plan guidance will have on industry. 

Siloed systems can make it difficult to marry data to support timely and informed decision-making and optimise clinical trial operations. And when data is not harmonised between systems, problems can quickly escalate. Read our latest feature in Applied Clinical Trials Magazine by Abby Sener, PMP, Manager of Almac ONE, to learn more on her thoughts in Applied Clinical Trials regarding the argument for Data Alignment and Integration in Clinical Supply Management. Read more: https://hubs.li/Q02DVbMT0